Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zoetis (NY:ZTS)

157.44 +1.79 (+1.15%)
Official Closing Price Updated: 7:00 PM EDT, May 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,654,777
Open 158.49
Bid (Size) 148.00 (1)
Ask (Size) 158.35 (1)
Prev. Close 155.65
Today's Range 156.68 - 159.97
52wk Range 139.70 - 200.33
Shares Outstanding 473,944,193
Dividend Yield 1.27%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
P/E Ratio Insights for Zoetis
Via Benzinga
1 Safe-and-Steady Stock to Target This Week and 2 to Be Wary Of
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory

Performance

YTD
-3.2%
-3.2%
1 Month
+3.8%
+3.8%
3 Month
-8.4%
-8.4%
6 Month
-10.1%
-10.1%
1 Year
-5.1%
-5.1%

More News

Read More
4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off
Via The Motley Fool
Topics Economy Intellectual Property World Trade
Exposures Economy Intellectual Property Tariff
1 Superstar Dividend Growth Stock to Buy if the Market Crashes
Via The Motley Fool
Topics Economy Government
Exposures Interest Rates Political
A Once-in-a-Decade Opportunity: 3 Magnificent Stocks Down Between 40% and 73% to Buy Right Now
Via The Motley Fool
Looking Into Zoetis's Recent Short Interest
Via Benzinga
3 Magnificent Stocks to Buy That Are Near 52-Week Lows
Via The Motley Fool
Topics Economy Government
Exposures COVID-19 Economy Political
2 of Wall Street’s Favorite Stocks with Competitive Advantages and 1 to Be Wary Of
Via StockStory
Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
This Magnificent Dividend Stock Has Increased Its Payouts by 500% in 10 Years
Via The Motley Fool
A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Zoetis' Stock Is About as Cheap as It's Ever Been. 1 Thing to Know Before You Buy.
Via The Motley Fool
Zoetis to Host Webcast and Conference Call on First Quarter 2025 Financial Results
From Zoetis Inc.
Via Business Wire
Unpacking Q4 Earnings: Pfizer (NYSE:PFE) In The Context Of Other Branded Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Stop Chasing Returns And Start Getting Rising Dividends With These 10 Blue Chip Stocks
Via Talk Markets
Topics Stocks / Equities
Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Zoetis (ZTS): Buy, Sell, or Hold Post Q4 Earnings?
Via StockStory
Topics Stocks
Exposures US Equities
Rule Breaker Investing: Pet Perks, Vol. 2
Via The Motley Fool
Discover the top S&P500 movers in Monday's pre-market session.
Via Chartmill
A Once-in-a-Decade Opportunity: 1 Magnificent S&P 500 Dividend Stock Down 36% to Double Up on Right Now
Via The Motley Fool
Topics Stocks
Exposures US Equities

Frequently Asked Questions

Is Zoetis publicly traded?
Yes, Zoetis is publicly traded.
What exchange does Zoetis trade on?
Zoetis trades on the New York Stock Exchange
What is the ticker symbol for Zoetis?
The ticker symbol for Zoetis is ZTS on the New York Stock Exchange
What is the current price of Zoetis?
The current price of Zoetis is 157.44
When was Zoetis last traded?
The last trade of Zoetis was at 05/02/25 07:00 PM ET
What is the market capitalization of Zoetis?
The market capitalization of Zoetis is 74.62B
How many shares of Zoetis are outstanding?
Zoetis has 75B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.